Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Pharmaceutical Sales Management 2008
Though the sales arms race is over, reps still overcrowd doctors waiting rooms today. Although the "more is better" selling technique employed by the largest of pharmas was successful through the late 1990s and early 2000s, the tactic quickly met the point of diminishing returns. Doctors, faced with seeing over 15 different reps over the course of a month, met the intrusions by closing offices to reps during certain times or shutting reps out completely.
In response to doctors negative reactions, a few industry leaders have now taken the step of restructuring their sales forces to reduce mirroring and once again establish more personal relationships with their targets.
Cutting Edge Informations report Pharmaceutical Sales Management 2008 analyzes present trends to provide the steps pharmaceutical sales managers must take to stay competitive - and beat the market.
The report makes its case with metrics and techniques for managing all three aspects of the current sales landscape:
* Investment, Structure and Management - Up-to-date investment levels, restructuring strategies, and territory management of major pharma sales forces
* Recruiting, Hiring, Training, and Sales Team Compensation - Building and maintaining forces to meet the new challenges and rapid changes of today
* In-Field Strategies - Maneuvers designed to strengthen sales reps in-field performance
Published 2007
185 Pages
250+ Metrics
110 Charts and Diagrams
PDF Format
Price: $7,695.00 / GBP3,847.50
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.